Filter
193
Filtered Results: 193
Text search:
teste
genotípico
Featured
Recommendations
28
New Publications
52
Language
Document type
No document type
109
Guidelines
39
Studies & Reports
25
Manuals
10
Strategic & Response Plan
7
Training Material
2
Fact sheets
1
Countries / Regions
Western and Central Europe
10
India
9
Eastern Europe
7
Colombia
6
Ethiopia
5
Africa
3
Venezuela
3
Latin America and the Carribbean
3
Myanmar / Burma
3
Kenya
2
Estonia
2
Mozambique
2
Global
2
Asia
2
South–East Asia Region
2
Paraguay
2
Argentina
2
Bangladesh
2
South Africa
2
Zambia
2
North Macedonia
1
Thailand
1
Lesotho
1
Benin
1
Sierra Leone
1
Chile
1
Nigeria
1
Senegal
1
Malawi
1
Philippines
1
USA
1
Tanzania
1
Eastern Europe and Central Asia
1
Uruguay
1
Bolivia
1
Uganda
1
Russia
1
Romania
1
Georgia
1
Botswana
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Policies & Guidelines HIV & TB
33
TB
13
Guidelines
11
Studies & Reports
8
Hepatitis
6
Policies
6
Pediatrics
5
Disease Prevention & Control
5
Bacteriology
4
Vaccine-preventable Diseases
4
HIV & STI
4
Malaria
4
Virology
3
Communicable Diseases
2
Countries
2
Capacity Building
2
Statistics
2
NTDs & Others
2
Paediatrics
1
Disaster Preparedness
1
COVID-19
1
Medical Devices & Equipment
1
Clinical Guidelines
1
Yellow Fever
1
Other
1
Toolboxes
Detection & Diagnosis
16
Drug resistant TB
12
ART Drug Resistance
10
Eastern Europe and central Asia
7
Surveillance
6
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
6
Adults
5
Children/Adolescents Mental Disorders
5
Children
5
Reports & Studies
5
Agriculture & Veterinary
4
Prevention & Control
4
Treatment Guidelines HIV
4
Drug resistance
4
Ethiopia
4
Studies
4
Training
4
Eastern Europe & Central Asia
4
Moldova
3
Clinical Aspects, Treatment & Prevention
3
Laboratory
3
Colombia
3
Antiretroviral Treatment ART
3
Surveillance
2
Country specific
2
Hepatitis
2
Public Health
2
TB
2
Adherence
2
Laboratory
2
Cannabis
2
General
2
Genomic sequencing
2
Other Countries
2
Clinical Aspects & Diagnostics
2
General
2
Co-Morbidities (except TB)
2
Disease Prevention & Control
2
Assessment
2
TB/HIV Coinfection
2
AmR (Region of Americas)
2
Kenya
2
SEAR (South-east Asia Region)
2
Drugs
1
Outbreak Prevention & Control
1
Policies & Strategies
1
Assessment & Studies
1
Biosafety
1
Meningitis Prevention & Control
1
Childhood TB
1
Laboratory Guidance
1
HIV testing & services
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Aspects
1
Clinical Guidelines
1
South Africa
1
WPRO (Western Pacific Region)
1
HIV
1
African Region
1
Mozambique
1
Georgia
1
Drug resistance
1
Country Guidelines
1
Reports
1
International
1
IEC Substance Use Disorders
1
Prevention & Preparedness
1
Supporting tools
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
TB/COVID-19
1
Chile
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
HIV &TB
1
Pharmacovigilance
1
Antimicrobial Resistance (AMR)
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Leptospirosis
1
Romania
1
Asia and Pacific
1
Substance Use Disorders & Addiction
1
Research & Access
1
Uganda
1
Clinical Guidelines
1
HIV and coinfection
1
Testing Guidelines
1
Nigeria
1
Chikungunya Prevention & Control
1
Others
1
South-east Asia Region
1
Context & Facts
1
Public Health
1
A survey of prevention, testing and treatment policies and practices
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care...
The modules (1-12) are based on materials originally developed by FIND, KNCV and Cepheid, and are in PowerPoint format for country customization. Depending on the audience, modules may be selected and adapted according to need (e.g. basic users, supervisors, clinicians). Topics covered include: Over...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
(updated December 2014).
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Policy framework.
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i...
Methicillin-resistant Staphylococcus aureus(MRSA) strainsor multidrug-resistant S.aureus, initially described in 1960s,emerged in the last decade as a cause of nosocomial infections responsible for rapidly progressive, potential fatal diseases including life-threatening pneumonia, necrotizing fascii...
Au cours de la dernière décennie, les données de séquençage génétique des agents pathogènes ont gagné en importance et contribuent désormais de façon déterminante à la détection et à la maîtrise des flambées de maladies infectieuses, en facilitant la mise au point de ...
